Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Medical Center Rodopimed EOOD

Bulgaria Ulitsa Osogovo 8, 6600 Kirdzhali, Bulgaria

  • 3 trials recruiting
  • Cardiac failure · Systemic lupus erythematosus · Hypertriglyceridaemia
  • Adult patients

About Specializations

Medical Center Rodopimed EOOD in Kirdzhali, Bulgaria specialises in clinical trials of conditions such as Cardiac failure, Systemic lupus erythematosus, Hypertriglyceridaemia, Chronic cutaneous lupus erythematosus, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology and Autoimmune Diseases

The medical center is at the forefront of research in rheumatology and autoimmune diseases, with a particular focus on Systemic Lupus Erythematosus (SLE). The center's ongoing studies aim to enhance the understanding and treatment of this complex condition.

  • Systemic Lupus Erythematosus (SLE)
  • Autoimmune Disease Management
  • Innovative Therapeutic Approaches

Through the investigation of novel therapies such as anifrolumab, the center is contributing to significant advancements in the management of moderate-to-severe SLE, offering hope for improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Osogovo 86600 KirdzhaliBulgaria
Open in maps ↗
Recruiting now
3 trials
Conditions studied
11

More sites in KirdzhaliBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Cardiac failure

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Systemic lupus erythematosus+3

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA

Cardiac failure

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Obesity+2

Not yet recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Hypertriglyceridaemia

Not recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Systemic lupus erythematosus

Not recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Axial spondyloarthritis

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.